KLK3 and prostate cancer: The percentage of men with PSA ≥20 ng/ml stage T1cN0M0 prostate cancer increased with age (5.3, 6.4, 7.6, and 13.3% for age groups 37–49, 50–64, 65–74, and ≥75, respectively).